Invasive aspergillosis is a fatal complication in leukaemic patients, sometimes involving the central nervous system (CNS). CNS aspergillosis is associated with high morbidity and mortality and its prognosis depends upon early diagnosis and prompt initiation of aggressive antifungal therapy (Calliot et al, 1997) . Invasive procedures such as stereotactic or percutaneous needle biopsy of the brain are required to diagnose CNS aspergillosis, but they are rarely permitted in leukaemic patients. Haemorrhagic infarctions and abscesses are frequently observed in CNS aspergillosis and meningeal involvement of Aspergillus is rare (Walsh et al, 1985) . However, Verweij et al (1997) recently described a patient in which CNS aspergillosis was successfully diagnosed using enzyme-linked immunosorbent assay (EIA) and polymerase chain reaction (PCR) of CSF samples. This report suggested that these assays may be bene®cial for the diagnosis of CNS aspergillosis because lumbar puncture is relatively easy and safe in patients without elevated intracranial pressures. Cerebral CT scan seems to be the most sensitive method for the diagnosis of CNS aspergillosis, but it is not speci®c for CNS aspergillosis. We may be able to make a correct diagnosis of CNS aspergillosis using cerebral CT scans and CSF examination. We therefore evaluated the usefulness of these assays in the diagnosis of CNS aspergillosis.
We diagnosed patients as de®nite invasive aspergillosis who had histological evidence of tissue invasion by branched septate hyphae or characteristic radiological ®ndings in the lung, together with the lack of response to antibacterial agents and positive culture for Aspergillus species from the sputa or lung. If patients had histological documentation of tissue invasion by branched septate hyphae in CNS samples with positive culture for Aspergillus species from the CNS lesions, we diagnosed them as CNS aspergillosis. CNS aspergillosis included cerebral infarctions, solitary or multiple abscesses and meningitis. CSF samples obtained from patients with CNS aspergillosis were subjected to PCR, latex agglutination test (LA) (Pastorex Aspergillus, Diagnostic Pasteur, France) and EIA (Platelia Aspergillus, Diagnostic Pasteur, France). Dilutions of the CSF samples were not used in this study. DNA extraction from CSF samples and PCR ampli®cation were performed as described previously (Verweij et al, 1997; Yamakami et al, 1996) .
We obtained ®ve CSF samples from ®ve patients with CNS aspergillosis. All of the patients had invasive pulmonary aspergillosis. The patients' characteristics and outcomes are shown in Table I . These patients manifested a variety of neurological signs, but meningeal signs were not observed in any patients. PCR of CSF samples identi®ed Aspergillus-speci®c DNA in all of the ®ve patients (100%) and both LA and ELISA detected the galactomannan antigen in four of the ®ve patients (80%). The sensitivities of PCR, EIA and LA were 100%, 80% and 80%, respectively. Using these methods, we were able to obtain speci®c ®ndings suggesting CNS aspergillosis in all of the patients. However, the fungal cultures were negative in all the patients.
For the control samples, we examined Aspergillus-speci®c DNA and the galactomannan antigens in 11 CSF samples obtained from patients with either leukaemic, bacterial, viral or mucor meningitis. All of the samples were negative for these assays which seemed to have a high speci®city (100%).
This study has several problems to be discussed. Firstly, there is a possibility of DNA contamination during PCR. However, contamination seemed to be minimal in this study since the control samples employed in every assay were always negative. Environmental contamination is the second problem since Aspergillus species are present in the environment. However, none of the control reagents and CSF samples of control patients were positive, implying that environmental contamination was negligible.
In conclusion, we showed that CSF examination may be bene®cial for the diagnosis of CNS aspergillosis. Positive results of PCR and the antigen detection methods may be a presentation of leakage of the soluble substances from brain lesions into CSF or may represent the involvement of a small number of Aspergillus hyphae in CSF, an amount that would not grow on Sabouroud medium, in CNS aspergillosis. Considering that Aspergillus meningeal involvement was not identi®ed in any patients with CNS aspergillosis (which was pathologically and microbiologically diagnosed), the former would seem to be the probable cause of the positive results of the CSF examination. However, we propose that CNS aspergillosis, either brain abscesses or cerebral infarctions, can be diagnosed by examining CSF with these sensitive assays. These methods do not require invasive procedures and may be suitable for patients with haematological malignancies. Short Report q 1999 Blackwell Science Ltd, British Journal of Haematology 106: 536±537 
